Terence A. Ketter

Original Research

Original Research

Consensus Statement

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Original Research

Academic Highlights

Original Research

Letter to the Editor

Original Research

Original Research

Original Research

Letter to the Editor

Original Research

Original Research

Letter to the Editor

Letter to the Editor

Letter to the Editor

Letter to the Editor

Original Research

Letter to the Editor

Original Research

Educational Activity

Educational Activity

Educational Activity

Educational Activity

Educational Activity

Educational Activity

Educational Activity

Consensus Statement

Original Research

Adjunctive Armodafinil for Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Proof-of-Concept Study

Analyses of Treatment-Emergent Mania With Olanzapine/Fluoxetine Combination in the Treatment of Bipolar Depression

Assessing Cognitive Function in Bipolar Disorder: Challenges and Recommendations for Clinical Trial Design

Bipolar CHOICE (Clinical Health Outcomes Initiative in Comparative Effectiveness): A Pragmatic 6-Month Trial of Lithium Versus Quetiapine for Bipolar Disorder

Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

Bipolar Therapeutics Update 2014: A Tale of 3 Treatments

Depressive Illness Burden Associated With Complex Polypharmacy in Patients With Bipolar Disorder: Findings From the STEP-BD

Dermatology Precautions and Slower Titration Yield Low Incidence of Lamotrigine Treatment-Emergent Rash

Differential Efficacy of Olanzapine and Lithium in Preventing Manic or Mixed Recurrence in Patients With Bipolar I Disorder Based on Number of Previous Manic or Mixed Episodes

The Effect of Dermatologic Precautions on the Incidence of Rash With Addition of Lamotrigine in the Treatment of Bipolar I Disorder: A Randomized Trial

Efficacy and Safety of Adjunctive Armodafinil in Adults With Major Depressive Episodes Associated With Bipolar I Disorder: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial

The Emerging Differential Roles of GABAergic and Antiglutamatergic Agents in Bipolar Disorders.

Extended-Release Carbamazepine Capsules as Monotherapy for Acute Mania in Bipolar Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Focus on Bipolar Disorder Treatment.

Incidence and Time Course of Subsyndromal Symptoms in Patients With Bipolar I Disorder: An Evaluation of 2 Placebo-Controlled Maintenance Trials

Increased Rate of Non-Right-Handedness in Patients With Bipolar Disorder

The Increasing Use of Polypharmacotherapy for Refractory Mood Disorders: 22 Years of Study

Monotherapy Versus Combined Treatment With Second-Generation Antipsychotics in Bipolar Disorder

A 6-Month, Multicenter, Open-Label Evaluation of Beaded, Extended-Release Carbamazepine Capsule Monotherapy in Bipolar Disorder Patients With Manic or Mixed Episodes

Mood Stabilization and Destabilization During Acute and Continuation Phase Treatment for Bipolar I Disorder With Lamotrigine or Placebo

Number Needed to Treat Can Be Helpful: A Response to Andrade

Olanzapine-Divalproex Combination Versus Divalproex Monotherapy in the Treatment of Bipolar Mixed Episodes: A Double-Blind, Placebo-Controlled Study

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Extended-Release Carbamazepine Capsules as Monotherapy for Bipolar Disorder Patients With Manic or Mixed Episodes

Predictors of Treatment Response in Bipolar Disorders: Evidence From Clinical and Brain Imaging Studies

Rapid Efficacy of Olanzapine Augmentation in Nonpsychotic Bipolar Mixed States

Reply to Letter to the Editor "Antiepileptic Drug Augmentation for Treatment-Resistant Depression"

Reply to Letter to the Editor "Olanzapine and Negative Symptoms"

Reply to Pharmacokinetic Drug-Drug Interactions Between Olanzapine and Valproate Need to Be Better Studied

Safety and Tolerability Associated With Second-Generation Antipsychotic Polytherapy in Bipolar Disorder: Findings From the Systematic Treatment Enhancement Program for Bipolar Disorder

Sensitive and Personalized Determinations of Likelihood of Being Helped or Harmed

The Texas Implementation of Medication Algorithms: Update to the Algorithms for Treatment of Bipolar I Disorder

Update on Best Practices for Managing Bipolar Depression

Nosology, Diagnostic Challenges, and Unmet Needs in Managing Bipolar Disorder

Strategies for the Early Recognition of Bipolar Disorder

Treating Bipolar Disorder: Monotherapy Versus Combination Therapy

Strategies for Monitoring Outcomes in Patients With Bipolar Disorder

Acute and Maintenance Treatments for Bipolar Depression

Combination Therapy Versus Monotherapy for Bipolar Disorder

Important Distinctions Between Bipolar I and Bipolar II Depression

Incorporating Clinical Trial Data Into Bipolar Disorder Management

Screening, Diagnosis, and Treatment of Tardive Dyskinesia

Baseline Disability and Poor Functioning in Bipolar Disorder Predict Worse Outcomes: Results From the Bipolar CHOICE Study

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles